Atlas Trials

Post Approval Observational Study to Learn More About How Safe Octocog Alfa is and How Well it Works in Patients With Severe Hemophilia A in India

Clinical trial NCT07446010 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07446010
Sponsor
Bayer
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Hemophilia A
Start date
2026-09-01
Primary completion
2027-09-30
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.